| scholarly article | Q13442814 |
| P50 | author | Rodrigo Guabiraba | Q56422355 |
| Rafael Elias Marques | Q29460201 | ||
| P2093 | author name string | Mauro Martins Teixeira | |
| Remo Castro Russo | |||
| P2860 | cites work | A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice | Q61386199 |
| Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice | Q61386204 | ||
| Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10 | Q61612313 | ||
| Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma | Q61895286 | ||
| Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium | Q63915251 | ||
| C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation | Q71802253 | ||
| Expression of RANTES mRNA and protein in airways of patients with mild asthma | Q71907032 | ||
| RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors | Q72072761 | ||
| Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma | Q73010328 | ||
| The source and role of RANTES in interstitial lung disease | Q73437079 | ||
| A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors | Q74015196 | ||
| Treatment of established asthma in a murine model using CpG oligodeoxynucleotides | Q74286507 | ||
| Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor | Q74477278 | ||
| Studies on disease-modifying antirheumatic drugs. III. Bone resorption inhibitory effects of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl) quinoline-3-carboxylate (TAK-603) and related compounds | Q77354311 | ||
| Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation | Q77929150 | ||
| Sustained inhibition of corneal neovascularization by genetic ablation of CCR5 | Q78853006 | ||
| Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage | Q79576278 | ||
| Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma | Q84203043 | ||
| CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis | Q42062154 | ||
| Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction | Q42125836 | ||
| Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation | Q42129651 | ||
| The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. | Q42152393 | ||
| The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness | Q42417164 | ||
| CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases | Q42605598 | ||
| Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice | Q43489161 | ||
| Asthma phenotypes in Japanese adults - their associations with the CCL5 and ADRB2 genotypes | Q43640373 | ||
| Early application of Met-RANTES ameliorates chronic allograft nephropathy | Q43889573 | ||
| Impaired T cell function in RANTES-deficient mice | Q43915327 | ||
| Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. | Q44533053 | ||
| Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation | Q44771104 | ||
| Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation | Q45723283 | ||
| Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. | Q45746421 | ||
| Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. | Q45999111 | ||
| In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031. | Q46847004 | ||
| Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. | Q47214393 | ||
| Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice | Q47846064 | ||
| Astrocytes modulate the chemokine network in a pathogen-specific manner | Q48262265 | ||
| Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection | Q48580707 | ||
| The unexpected pleiotropic activities of RANTES. | Q51758914 | ||
| The role of complement and complement receptors in induction and regulation of immunity. | Q53992218 | ||
| The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 | Q56942537 | ||
| Housekeeping by chemokine scavenging | Q56942686 | ||
| Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium | Q57574602 | ||
| Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo | Q57790213 | ||
| Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients | Q57955827 | ||
| Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans | Q22255463 | ||
| Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils | Q24293111 | ||
| Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 | ||
| Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 | Q24534620 | ||
| Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection | Q24646031 | ||
| Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes | Q24674124 | ||
| CCR5 deficiency increases risk of symptomatic West Nile virus infection | Q24677652 | ||
| Subversion of cytokine networks by virally encoded decoy receptors | Q27005694 | ||
| Rabies Virus Nucleoprotein Functions To Evade Activation of the RIG-I-Mediated Antiviral Response | Q27491327 | ||
| International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature | Q28201568 | ||
| Chemokine: receptor structure, interactions, and antagonism | Q28287562 | ||
| A human T cell-specific molecule is a member of a new gene family | Q28307933 | ||
| SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo | Q28362194 | ||
| CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection | Q28508659 | ||
| RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans | Q28567974 | ||
| Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice | Q28579311 | ||
| Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Innate immune response of human alveolar macrophages during influenza A infection | Q28731580 | ||
| Origin and physiological roles of inflammation | Q29614298 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
| Points of control in inflammation | Q29620319 | ||
| A broad spectrum secreted chemokine binding protein encoded by a herpesvirus | Q30326102 | ||
| Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment | Q30415355 | ||
| Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages. | Q30427498 | ||
| A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. | Q31395542 | ||
| TLR3-mediated synthesis and release of eotaxin-1/CCL11 from human bronchial smooth muscle cells stimulated with double-stranded RNA. | Q33267229 | ||
| Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo. | Q33552532 | ||
| A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination | Q33793526 | ||
| Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia | Q33987385 | ||
| Treatment of yellow fever | Q34008580 | ||
| The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness | Q34009861 | ||
| Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression | Q34150874 | ||
| Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection | Q34192857 | ||
| RANTES: a versatile and controversial chemokine | Q34207569 | ||
| Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines | Q34264032 | ||
| Chemokine receptor oligomerization: functional considerations. | Q37614674 | ||
| Human cytomegalovirus encodes a highly specific RANTES decoy receptor | Q37692751 | ||
| Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists? | Q37769492 | ||
| Homeostatic chemokine receptors and organ-specific metastasis | Q37922092 | ||
| The role of chemokines in the pathogenesis of neurotropic flaviviruses | Q38006657 | ||
| Resolution of inflammation: mechanisms and opportunity for drug development. | Q38098770 | ||
| Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender | Q38882456 | ||
| IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection | Q39034933 | ||
| Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. | Q39464587 | ||
| Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice | Q39639458 | ||
| CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis | Q39818502 | ||
| Hantaan virus triggers TLR3-dependent innate immune responses | Q39881068 | ||
| Ticks produce highly selective chemokine binding proteins with antiinflammatory activity | Q40063162 | ||
| Cytokine induction by respiratory syncytial virus and adenovirus in bronchial epithelial cells | Q40179710 | ||
| Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity | Q40287490 | ||
| A dual role for tumor-derived chemokine RANTES (CCL5). | Q40605555 | ||
| The impact of dengue haemorrhagic fever on liver function | Q40648593 | ||
| The molecular biology of leukocyte chemoattractant receptors | Q40661169 | ||
| A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection | Q40845773 | ||
| A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. | Q41091668 | ||
| Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation | Q41133441 | ||
| Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. | Q41229926 | ||
| Molecular mechanisms of blood vessel formation | Q41560712 | ||
| CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations | Q41839089 | ||
| Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function | Q41861205 | ||
| Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. | Q34344625 | ||
| Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes | Q34365709 | ||
| A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation | Q34389532 | ||
| The chemokine receptor D6 limits the inflammatory response in vivo | Q34400531 | ||
| Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors | Q34441628 | ||
| Role of chemokines in the pathogenesis of asthma | Q34572155 | ||
| Absence of CCR5 increases neutrophil recruitment in severe herpetic encephalitis | Q34580437 | ||
| Chemokines in atherosclerosis: an update | Q34656531 | ||
| A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis | Q34733739 | ||
| Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation | Q34740114 | ||
| Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 | ||
| Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis | Q35018318 | ||
| Role of CCL5 (RANTES) in viral lung disease. | Q35024052 | ||
| C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
| Chemokine regulation of inflammation during acute viral infection | Q35581722 | ||
| Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo | Q35701867 | ||
| Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. | Q35773727 | ||
| Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. | Q35781428 | ||
| Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells | Q35809825 | ||
| The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines | Q35886322 | ||
| HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines | Q35943318 | ||
| MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. | Q36141697 | ||
| CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease | Q36177928 | ||
| The role of chemokines during herpes simplex virus-1 infection | Q36726766 | ||
| Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues | Q36742483 | ||
| The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection | Q36944050 | ||
| Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection | Q36986897 | ||
| Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes | Q37073520 | ||
| RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge | Q37098568 | ||
| Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. | Q37115634 | ||
| How chemokines invite leukocytes to dance | Q37246681 | ||
| Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production | Q37333841 | ||
| T cell homing to epithelial barriers in allergic disease | Q37392523 | ||
| The roles of chemokines in rabies virus infection: overexpression may not always be beneficial | Q37410626 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 1439-1460 | |
| P577 | publication date | 2013-10-03 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Targeting CCL5 in inflammation | |
| P478 | volume | 17 |
| Q38679146 | Bone healing in an aged murine fracture model is characterized by sustained callus inflammation and decreased cell proliferation. |
| Q48182998 | CCL5 Promotes Resolution-Phase Macrophage Reprogramming in Concert with the Atypical Chemokine Receptor D6 and Apoptotic Polymorphonuclear Cells |
| Q37058153 | CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells |
| Q93087227 | CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization |
| Q64116780 | Calcium Dyshomeostasis Alters CCL5 Signaling in Differentiated PC12 Cells |
| Q36529592 | Comparison of the pathogen species-specific immune response in udder derived cell types and their models |
| Q99240709 | Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective |
| Q33703305 | Deguelin Attenuates Allergic Airway Inflammation via Inhibition of NF-κb Pathway in Mice |
| Q64280207 | Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity |
| Q26700116 | Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development |
| Q30842619 | Development of a model of Saint Louis encephalitis infection and disease in mice |
| Q35833605 | Effects of 60-day bed rest with and without exercise on cellular and humoral immunological parameters |
| Q37707505 | Epigenetic Modification of the CCL5/CCR1/ERK Axis Enhances Glioma Targeting in Dedifferentiation-Reprogrammed BMSCs. |
| Q96128194 | Fibroblast Growth Factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells |
| Q40217705 | Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation. |
| Q37546954 | Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver |
| Q47836493 | Glial- and Neuronal-Specific Expression of CCL5 mRNA in the Rat Brain. |
| Q94468378 | Host genetic susceptibility to mycetoma |
| Q48355113 | Immunological characterization of the early human fracture hematoma |
| Q58765729 | Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury |
| Q28817598 | Mature IgM-expressing plasma cells sense antigen and develop competence for cytokine production upon antigenic challenge |
| Q90692421 | Modelling Lyssavirus Infections in Human Stem Cell-Derived Neural Cultures |
| Q26800158 | Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs |
| Q40813688 | Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding. |
| Q39072710 | Perivascular adipose tissue inflammation in vascular disease |
| Q36195750 | Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study. |
| Q64108184 | Production of an aberrant splice variant of CCL5 is not caused by genetic mutation in the mammary glands of mastitis‑infected Holstein cows |
| Q51528101 | Protein profiles of CCL5, HPGDS, and NPSR1 in plasma reveal association with childhood asthma. |
| Q49500593 | Role of CCL5/CCR5 in the perineural invasion of salivary adenoid cystic carcinoma cells |
| Q36812077 | Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. |
| Q92068069 | Screening TCGA database for prognostic genes in lower grade glioma microenvironment |
| Q37408794 | Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise |
| Q91809716 | Stabilized Interleukin-4-Loaded Poly(lactic-co-glycolic) Acid Films Shift Proinflammatory Macrophages toward a Regenerative Phenotype in Vitro |
| Q35860612 | The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH |
| Q92327821 | The Puzzling Role of Neuron-Specific PMCA Isoforms in the Aging Process |
| Q55333229 | The effect of down-regulation of CCL5 on lipopolysaccharide-induced WI-38 fibroblast injury: a potential role for infantile pneumonia. |
| Q38254356 | The potential to target CCL5/CCR5 in breast cancer. |
| Q64087575 | Toll-like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes |
| Q92620708 | Transcriptomic analysis of immune response to bacterial lipopolysaccharide in zebra finch (Taeniopygia guttata) |
| Q36546383 | Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development. |
Search more.